# Glaxosmithkline Holdings (Americas) Inc.

Canonical: https://abierto.us/vendors/glaxosmithkline-holdings-americas-inc-qqh9khxncg81

- UEI: QQH9KHXNCG81
- CAGE: 93544
- Parent: Glaxosmithkline PLC
- Location: Philadelphia, PA
- Awards in window: 3 (3 transactions), -$5,525,797 obligated, January 8, 2025 to January 9, 2025

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 3 awards, -$5,525,797

## Industries

- 325412 Pharmaceutical Preparation Manufacturing: -$1
- 325414 Biological Product (except Diagnostic) Manufacturing: -$5,525,796

## Competition

- Not Competed: 2 awards
- Full and Open Competition: 1 awards

## Largest awards

- HHSO100200900123C (definitive contract): -$1, Barda - Aspr / Daappo / Barda DCMA. Close Contract and Deobligate .60. https://www.usaspending.gov/award/CONT_AWD_HHSO100200900123C_7505_-NONE-_-NONE-/
- HHSO100200600016I: -$1,303,449, Barda - Aspr / Daappo / Barda DCMA. Deobligation of Excess Funds. https://www.usaspending.gov/award/CONT_IDV_HHSO100200600016I_7505/
- HHSO100200600011C (definitive contract): -$4,222,347, Barda - Aspr / Daappo / Barda DCMA. Contract Closeout Deobligate Excess Funds. https://www.usaspending.gov/award/CONT_AWD_HHSO100200600011C_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/glaxosmithkline-holdings-americas-inc-qqh9khxncg81.